- Home
- CSTL vs FDUS Comparison
CSTL vs FDUS Comparison
Compare CSTL & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- FDUS
- Stock Information
- Founded
- CSTL 2007
- FDUS 2011
- Country
- CSTL United States
- FDUS United States
- Employees
- CSTL N/A
- FDUS N/A
- Industry
- CSTL Medical Specialities
- FDUS Finance/Investors Services
- Sector
- CSTL Health Care
- FDUS Finance
- Exchange
- CSTL Nasdaq
- FDUS Nasdaq
- Market Cap
- CSTL 848.1M
- FDUS 759.3M
- IPO Year
- CSTL 2019
- FDUS 2011
- Fundamental
- Price
- CSTL $25.75
- FDUS $23.06
- Analyst Decision
- CSTL Strong Buy
- FDUS
- Analyst Count
- CSTL 6
- FDUS 0
- Target Price
- CSTL $40.33
- FDUS N/A
- AVG Volume (30 Days)
- CSTL 358.8K
- FDUS 149.6K
- Earning Date
- CSTL 02-27-2025
- FDUS 03-03-2025
- Dividend Yield
- CSTL N/A
- FDUS 10.02%
- EPS Growth
- CSTL N/A
- FDUS 26.64
- EPS
- CSTL 0.21
- FDUS 2.78
- Revenue
- CSTL $311,878,000.00
- FDUS $145,008,000.00
- Revenue This Year
- CSTL $51.99
- FDUS $13.81
- Revenue Next Year
- CSTL N/A
- FDUS $0.02
- P/E Ratio
- CSTL $122.41
- FDUS $8.30
- Revenue Growth
- CSTL 62.43
- FDUS 19.57
- 52 Week Low
- CSTL $16.97
- FDUS $18.41
- 52 Week High
- CSTL $35.84
- FDUS $23.55
- Technical
- Relative Strength Index (RSI)
- CSTL 37.34
- FDUS 66.32
- Support Level
- CSTL $26.65
- FDUS $22.28
- Resistance Level
- CSTL $28.48
- FDUS $23.55
- Average True Range (ATR)
- CSTL 1.12
- FDUS 0.26
- MACD
- CSTL -0.17
- FDUS 0.00
- Stochastic Oscillator
- CSTL 0.94
- FDUS 61.42
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.